Target intelligence / Profile preview

Gram-negative enteric bacterial surface antigens

Molecular classification
Antigen, Lipopolysaccharide, Outer membrane protein, Glycan
01

Overview

Gram-negative enteric bacterial surface antigens represent a broad category of molecular structures located on the outer membrane of bacteria within the Enterobacteriaceae family and related genera. These include lipopolysaccharides (LPS), which consist of Lipid A (an endotoxin), a core polysaccharide, and the highly variable O-antigen, as well as flagellar (H) and capsular (K) antigens. These molecules are critical for the structural integrity of the bacteria and play a central role in host-pathogen interactions, often serving as primary targets for the host's immune system during an infection. In a therapeutic context, these antigens are utilized in the development of polyvalent bacterial lysates and vaccines designed to boost mucosal immunity and prevent recurrent infections, such as urinary or respiratory tract infections. Additionally, they have been the focus of monoclonal antibody development aimed at neutralizing endotoxins or promoting bacterial clearance in cases of severe sepsis, although many such targeted therapies have faced significant challenges in clinical efficacy. (Sources: StatPearls: Gram Negative Bacteria; PubMed: PMCID PMC7150055; NIH: Bacterial Antigenic Structures).

Other names
Enteric bacterial antigensGram-negative surface antigensLipopolysaccharidesOuter membrane proteinsO-antigensH-antigensK-antigens
02

Mechanism of action

Stimulation of the innate and adaptive immune systems through exposure to bacterial components, or direct neutralization and opsonization by monoclonal antibodies to facilitate phagocytosis and clearance.

03

Biological functions

Immune responseCell adhesionPathogenicityStructural integrityImmune evasion
04

Disease associations

InfectionSepsisGastroenteritisUrinary tract infection
05

Safety considerations

EndotoxicityJarisch-Herxheimer reactionCross-reactivity with host tissuesHypersensitivity reactions
06

Interacting drugs

Bacterial lysates (e.g., Uro-Vaxom, Broncho-Vaxom)

3 more in the full profile.

07

Biomarkers

Antibody titers (IgG, IgA)C-reactive protein (CRP)ProcalcitoninBacterial load

Beyond the preview

Go deeper on Gram-negative enteric bacterial surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative enteric bacterial surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call